Paneth cells and necrotizing enterocolitis: A novel hypothesis for disease pathogenesis

Neonatology

Volumn 103, Issue 1, 2012, Pages 10-20

  McElroy, Steven J ^a   Underwood, Mark A ^b   Sherman, Michael P ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Defensins; Dithizone; Enteric infection; Ileal necrosis; Intestinal crypts; Paneth cell ablation; Paneth cell related gut injury and repair; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; DITHIZONE; EPIDERMAL GROWTH FACTOR; HYDROCORTISONE; INTERLEUKIN 1BETA; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BLOOD CLOTTING DISORDER; CELL DIFFERENTIATION; CELL PROTECTION; CORTICOSTEROID THERAPY; CROHN DISEASE; CYTOKINE RELEASE; DISEASE MODEL; ENTERITIS; HUMAN; INTESTINE CELL; INTESTINE CRYPT; INTESTINE FLORA; INTESTINE MUCOSA; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; SUBMUCOSA;

ANIMALS; CONCEPT FORMATION; DISEASE; ENTEROCOLITIS, NECROTIZING; HEALTH; HUMANS; INFANT, NEWBORN; INTESTINAL MUCOSA; MICE; MODELS, BIOLOGICAL; PANETH CELLS;

ANIMALIA; MUS;

EID: 84866499045     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000342340     Document Type: Review

References (80)

1. Kliegman RM, Fanaroff AA: Necrotizing enterocolitis. N Engl J Med 1984; 310: 1093-1103. (Pubitemid 14131503)
2. Neu J, Walker WA: Necrotizing enterocolitis. N Engl J Med 2011; 364: 255-264.
3. Hsueh W, De Plaen IG, Caplan MS, Qu XW, Tan XD, Gonzalez-Crussi F: Neonatal necrotizing enterocolitis: clinical aspects, experimental models and pathogenesis. World J Pediatr 2007; 3: 17-29. (Pubitemid 46895252)
4. Grave GD, Nelson SA, Walker WA, Moss RL, Dvorak B, Hamilton FA, Higgins R, Raju TN: New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res 2007; 62: 510-514. (Pubitemid 47476215)
5. Afrazi A, Sodhi CP, Richardson W, Neal M, Good M, Siggers R, Hackam DJ: New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatr Res 2011; 69: 183-188.
6. Berman L, Moss RL: Necrotizing enterocolitis: an update. Semin Fetal Neonatal Med 2011; 16: 145-150.
7. Carlisle EM, Poroyko V, Caplan MS, Alverdy JA, Liu D: Gram negative bacteria are associated with the early stages of necrotizing enterocolitis. PLoS One 2011; 6:e18084.
8. Sampath V, Le M, Lane L, Patel AL, Cohen JD, Simpson PM, Garland JS, Hines RN: The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res 2011; 169:e51-e57.
9. Morrow AL, Meinzen-Derr J, Huang P, Schibler KR, Cahill T, Keddache M, Kallapur SG, Newburg DS, Tabangin M, Warner BB, Jiang X: Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants. J Pediatr 2011; 158: 745-751.
10. Bisquera JA, Cooper TR, Berseth CL: Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics 2002; 109: 423-428. (Pubitemid 34177504)
11. Spencer AU, Kovacevich D, McKinney-Barnett M, Hair D, Canham J, Maksym C, Teitelbaum DH: Pediatric short-bowel syndrome: the cost of comprehensive care. Am J Clin Nutr 2008; 88: 1552-1559.
12. Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, Poole WK, Blakely ML, Wright L, Higgins R, NICHD Neonatal Research Network: Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005; 115: 696-703. (Pubitemid 43373031)
13. Martin CR, Dammann O, Allred EN, Patel S, O'Shea TM, Kuban KC, Leviton A: Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia. J Pediatr 2010; 157: 751-756. e1.
14. Torres C, Sudan D, Vanderhoof J, Grant W, Botha J, Raynor S, Langnas A: Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr 2007; 45: 204-212. (Pubitemid 47220529)
15. Kochanek KD, Smith BL: Deaths: preliminary data for 2002. Natl Vital Stat Rep 2002; 52: 1-47.
16. Murphy SL, Xu J, Kochanek KD: Deaths: preliminary data for 2010. Natl Vital Stat Rep 2012; 60: 1-68.
17. Obladen M: Necrotizing enterocolitis-150 years of fruitless search for the cause. Neonatology 2009; 96: 203-210.
18. Schnabl KL, Van Aerde JE, Thomson AB, Clandinin MT: Necrotizing enterocolitis: a multifactorial disease with no cure. World J Gastroenterol 2008; 14: 2142-2161.
19. Emami CN, Petrosyan M, Giuliani S, Williams M, Hunter C, Prasadarao NV, Ford HR: Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis. Surg Infect (Larchmt) 2009; 10: 407-417.
20. Viscardi RM, Lyon NH, Sun CC, Hebel JR, Hasday JD: Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine. Pediatr Pathol Lab Med 1997; 17: 547-559. (Pubitemid 27263929)
21. Sántulli TV, Schullinger JN, Heird WC, Gongaware RD, Wigger J, Barlow B, Blanc WA, Berdon WE: Acute necrotizing enterocolitis in infancy: a review of 64 cases. Pediatrics 1975; 55: 376-387.
22. Nowicki PT: Ischemia and necrotizing enterocolitis: where, when, and how. Semin Pediatr Surg 2005; 14: 152-158. (Pubitemid 41111601)
23. Nankervis CA, Giannone PJ, Reber KM: The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis. Semin Perinatol 2008; 32: 83-91. (Pubitemid 351381165)
24. Ballance WA, Dahms BB, Shenker N, Kliegman RM: Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr 1990; 117:S6-S13. (Pubitemid 20219504)
25. Epelman M, Daneman A, Navarro OM, Morag I, Moore AM, Kim JH, Faingold R, Taylor G, Gerstle JT: Necrotizing enterocolitis: review of state-of-the-art imaging findings with pathologic correlation. Radiographics 2007; 27: 285-305.
26. Hill HR, Hunt CE, Matsen JM: Nosocomial colonization with Klebsiella, type 26, in a neonatal intensive-care unit associated with an outbreak of sepsis, meningitis, and necrotizing enterocolitis. J Pediatr 1974; 85: 415-419.
27. Smith B, Bodé S, Petersen BL, Jensen TK, Pipper C, Kloppenborg J, Boyé M, Krogfelt KA, Mølbak L: Community analysis of bacteria colonizing intestinal tissue of neonates with necrotizing enterocolitis. BMC Microbiol 2011; 11: 73.
28. Sawada M, Takahashi K, Sawada S, Midorikawa O: Selective killing of Paneth cells by intravenous administration of dithizone in rats. Int J Exp Pathol 1991; 72: 407-421.
29. Sherman MP, Bennett SH, Hwang FF, Sherman J, Bevins CL: Paneth cells and antibacterial host defense in neonatal small intestine. Infect Immun 2005; 73: 6143-6146. (Pubitemid 41193054)
30. Zhang C, Sherman MP, Prince LS, Bader D, Weitkamp JH, Slaughter JC, McElroy SJ: Paneth cell ablation in the presence of Klebsiella pneumoniae induces necrotizing enterocolitis (NEC)-like injury in the small intestine of immature mice. Dis Model Mech 2012; 5: 522-532.
31. Ouellette AJ, Niklas V: Paneth cells in intestinal health and disease in the newborn. Neo Rev 2010; 11:e551-e557.
32. Selsted ME, Miller SI, Henschen AH, Ouellette AJ: Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol 1992; 118: 929-936.
33. Jones DE, Bevins CL: Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992; 267: 23216-23225.
34. Qu XD, Lloyd KC, Walsh JH, Lehrer RI: Secretion of type II phospholipase A 2 and cryptdin by rat small intestinal Paneth cells. Infect Immun 1996; 64: 5161-5165. (Pubitemid 26403975)
35. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ: Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1: 113-118.
36. Lehrer RI, Lu W: Defensins in human innate immunity. Immunol Rev 2012; 245: 84-112.
37. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL: Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422: 522-526. (Pubitemid 36433647)
38. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV: Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA 2008; 105: 20858-20863.
39. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjöberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, Stoel M, Zhou Y, Sodergren E, Weinstock GM, Bevins CL, Williams CB, Bos NA: Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11: 76-83.
40. Ganz T: Paneth cells-guardians of the gut cell hatchery. Nat Immunol 2000; 1: 99-100.
41. Behnke O, Moe H: An electron microscope study of mature and differentiating Paneth cells in the rat, especially of their endoplasmic reticulum and lysozymes. J Cell Biol 1964; 22: 633-652.
42. Stappenbeck TS, Hooper LV, Gordon JI: Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99: 15451-15455. (Pubitemid 35403955)
43. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI: Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003; 4: 269-273. (Pubitemid 36322137)
44. Vereecke L, Beyaert R, van Loo G: Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol Med 2011; 17: 584-593.
45. Yilmaz OH, Katajisto P, Lamming DW, Gültekin Y, Bauer-Rowe KE, Sengupta S, Birsoy K, Dursun A, Yilmaz VO, Selig M, Nielsen GP, Mino-Kenudson M, Zukerberg LR, Bhan AK, Deshpande V, Sabatini DM: mTORC1 in the Paneth cell niche couples intestinal stemcell function to calorie intake. Nature 2012; 486: 490-495.
46. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M, Clevers H: Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011; 469: 415-418.
47. Seno H, Sawada M, Fukuzawa H, Morita-Fujisawa Y, Takaishi S, Hiai H, Chiba T: Involvement of tumor necrosis factor alpha in intestinal epithelial cell proliferation following Paneth cell destruction. Scand J Gastroenterol 2002; 37: 154-160. (Pubitemid 34102250)
48. Wehkamp J, Stange EF: Paneth's disease. J Crohns Colitis 2010; 4: 523-531.
49. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J Leukoc Biol 2006; 80: 500-508. (Pubitemid 44835783)
50. Ordás I, Feagan BG, Sandborn WJ: Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change. Gut 2011; 60: 1754-1763.
51. Tan X, Hsueh W, Gonzalez-Crussi F: Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages. Am J Pathol 1993; 142: 1858-1865. (Pubitemid 24057080)
52. McElroy SJ, Prince LS, Weitkamp JH, Reese J, Slaughter JC, Polk DB: Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2011; 301:G656-G666.
53. Rumio C, Sommariva M, Sfondrini L, Palazzo M, Morelli D, Viganò L, De Cecco L, Tagliabue E, Balsari A: Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands. J Cell Physiol 2012; 227: 1107-1113.
54. Geffers C, Baerwolff S, Schwab F, Gastmeier P: Incidence of healthcare-associated infections in high-risk neonates: results from the German surveillance system for very-lowbirthweight infants. J Hosp Infect 2008; 68: 214-221.
55. González-Rivera R, Culverhouse RC, Hamvas A, Tarr PI, Warner BB: The age of necrotizing enterocolitis onset: an application of Sartwell's incubation period model. J Perinatol 2011; 31: 519-523.
56. Yee WH, Soraisham AS, Shah VS, Aziz K, Yoon W, Lee SK, Canadian Neonatal Network: Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 2012; 129:e298-e304.
57. Mallow EB, Harris A, Salzman N, Russell JP, DeBerardinis RJ, Ruchelli E, Bevins CL: Human enteric defensins. Gene structure and developmental expression. J Biol Chem 1996; 271: 4038-4045.
58. Underwood MA, Kananurak A, Coursodon CF, Adkins-Reick CK, Chu H, Bennett SH, Wehkamp J, Castillo PA, Leonard BC, Tancredi DJ, Sherman MP, Dvorak B, Bevins CL: Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses. Pediatr Res 2012; 71: 546-551.
59. Salzman NH, Polin RA, Harris MC, Ruchelli E, Hebra A, Zirin-Butler S, Jawad A, Martin Porter E, Bevins CL: Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 1998; 44: 20-26. (Pubitemid 28303439)
60. Coutinho HB, da Mota HC, Coutinho VB, Robalinho TI, Furtado AF, Walker E, King G, Mahida YR, Sewell HF, Wakelin D: Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol 1998; 51: 512-514. (Pubitemid 28375030)
61. Schaart MW, de Bruijn AC, Bouwman DM, de Krijger RR, van Goudoever JB, Tibboel D, Renes IB: Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr 2009; 49: 31-41.
62. Underwood MA, Bevins CL: Defensinbarbed innate immunity: clinical associations in the pediatric population. Pediatrics 2010; 125: 1237-1247.
63. Günther C, Neumann H, Neurath MF, Becker C: Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 2012, Epub ahead of print.
64. Chu H, Pazgier M, Jung G, Nuccio SP, Castillo PA, de Jong MF, Winter MG, Winter SE, Wehkamp J, Shen B, Salzman NH, Underwood MA, Tsolis RM, Young GM, Lu W, Lehrer RI, Bäumler AJ, Bevins CL: Human-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 2012; 337: 477-481.
65. Takahashi N, Vanlaere I, de Rycke R, Cauwels A, Joosten LA, Lubberts E, van den Berg WB, Libert C: IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med 2008; 205: 1755-1761.
66. Zhang T, Desimone RA, Jiao X, Rohlf FJ, Zhu W, Gong QQ, Hunt SR, Dassopoulos T, Newberry RD, Sodergren E, Weinstock G, Robertson CE, Frank DN, Li E: Host genes related to paneth cells and xenobiotic metabolism are associated with shifts in human ileum-associated microbial composition. PLoS One 2012; 7:e30044.
67. Karlsson J, Pütsep K, Chu H, Kays RJ, Bevins CL, Andersson M: Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract. BMC Immunol 2008; 9: 37.
68. Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, Theriaque D, Li N, Sharma R, Hudak M, Neu J: Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 2011; 6:e20647.
69. Bauer CR, Morrison JC, Poole WK, Korones SB, Boehm JJ, Rigatto H, Zachman RD: A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics 1984; 73: 682-688. (Pubitemid 14143981)
70. Coutinho VB, Coutinho HB, Coutinho EM: Effects of hydrocortisone acetate treatment on the small intestine of the lactent marsupial Didelphis albiventris. Anat Anz 1991; 172: 213-221.
71. Maynard AA, Dvorak K, Khailova L, Dobrenen H, Arganbright KM, Halpern MD, Kurundkar AR, Maheshwari A, Dvorak B: Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010; 299:G614-G622.
72. Raaberg L, Nexø E, Damsgaard Mikkelsen J, Seier Poulsen S: Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat. Histochemistry 1988; 89: 351-356.
73. Thachil E, Hugot JP, Arbeille B, Paris R, Grodet A, Peuchmaur M, Codogno P, Barreau F, Ogier-Denis E, Berrebi D, Viala J: Abnormal activation of autophagy-induced crinophagy in Paneth cells from patients with Crohn's disease. Gastroenterology 2012; 142: 1097-1099. e4.
74. Deshpande G, Rao S, Patole S, Bulsara M: Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125: 921-930.
75. Wang Q, Dong J, Zhu Y: Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birthweight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012; 47: 241-248.
76. Kingma SD, Li N, Sun F, Valladares RB, Neu J, Lorca GL: Lactobacillus johnsonii N6. 2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. J Nutr 2011; 141: 1023-1028.
77. Wrackmeyer U, Hansen GH, Seya T, Danielsen EM: Intelectin: a novel lipid raft-associated protein in the enterocyte brush border. Biochemistry 2006; 45: 9188-9197. (Pubitemid 44156382)
78. Shin K, Wakabayashi H, Yamauchi K, Yaeshima T, Iwatsuki K: Recombinant human intelectin binds bovine lactoferrin and its peptides. Biol Pharm Bull 2008; 31: 1605-1608.
79. Sherman MP, Adamkin DH, Radmacher PG, Sherman J, Niklas V: Protective proteins in mammalian milks: lactoferrin steps forward. Neo Rev 2012; 13:e293-e300.
80. Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H, Stolfi I, Decembrino L, Laforgia N, Vagnarelli F, Memo L, Bordignon L, Saia OS, Maule M, Gallo E, Mostert M, Magnani C, Quercia M, Bollani L, Pedicino R, Renzullo L, Betta P, Mosca F, Ferrari F, Magaldi R, Stronati M, Farina D, Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology: Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009; 302: 1421-1428.